great call watso with your comment.. ie
"Not many analysts cover gda these days, but following the inclusion of gda, in the ASX 200 "biggest dog stocks" (penny featherweight class), the team at watso corporate, have resumed coverage.
Recommendation BUY at 0.9c ..
Target price 0.5c.
Clients, with a risk averse approach to investing, and who are looking for a certain tax deduction, for june 30 next year, are urged to buy the stock."
the shares are now .6c
further in the same thread, after the shares had spiked a bit, watso reaffirmed his buy recommendation with ...
"for those looking for an exciting tax loss position, for this financial year, then the stock is an outstanding buy at 1.5c. an even bigger tax loss, will be available to the canny investor, who snapped up the shares at 1.9c"
- Forums
- ASX - By Stock
- GDA
- watso recommences coverage of gda
watso recommences coverage of gda, page-21
Featured News
Add GDA (ASX) to my watchlist
(20min delay)
|
|||||
Last
29.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $35.67M |
Open | High | Low | Value | Volume |
29.5¢ | 29.5¢ | 28.3¢ | $6.079K | 20.76K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 168481 | 29.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
30.0¢ | 67036 | 3 |
Last trade - 13.27pm 25/11/2024 (20 minute delay) ? |
Featured News
GDA (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online